Ischemic Heart Disease Clinical Trials

54 recruiting

Ischemic Heart Disease Trials at a Glance

58 actively recruiting trials for ischemic heart disease are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 26 trials, with the heaviest enrollment activity in Barcelona, Ciudad Real, and León. Lead sponsors running ischemic heart disease studies include Fundación EPIC, Beijing Tiantan Hospital, and Aarhus University Hospital Skejby.

Browse ischemic heart disease trials by phase

Treatments under study

About Ischemic Heart Disease Clinical Trials

Looking for clinical trials for Ischemic Heart Disease? There are currently 54 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ischemic Heart Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ischemic Heart Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 58 trials

Recruiting

Coroflex® ISAR NEO PMCF Study

Coronary Artery Disease (CAD)Ischemic Heart Disease
Fundación EPIC3,000 enrolled22 locationsNCT05698732
Recruiting

Association Between Radial Artery Intervention and Development of Neuropathy in the Hand - A Prospective Study

Nerve InjuryIschemic Heart Disease
Aarhus University Hospital Skejby400 enrolled1 locationNCT05365282
Recruiting

Sequent Extended Study

Coronary Artery DiseaseIschemic Heart Disease
Fundación EPIC2,028 enrolled27 locationsNCT05788432
Recruiting

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Coronary Artery DiseaseIschemic Heart Disease
Fundación EPIC500 enrolled10 locationsNCT06863155
Recruiting

A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation

CardiomyopathyCardiac AmyloidosisIschemic Heart Disease
Mayo Clinic10,040,000 enrolled1 locationNCT07308704
Recruiting
Not Applicable

The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

Cardiac Magnetic Resonance ImagingIschemic Heart Disease (IHD)Myocardial Blood Flow
Brigham and Women's Hospital1,000 enrolled10 locationsNCT06854458
Recruiting

LONG NAGOMI™ PMCF STUDY

Coronary Artery DiseaseIschemic Heart Disease
Fundación EPIC1,039 enrolled6 locationsNCT07399002
Recruiting
Not Applicable

A Clinical Evaluation of AMJ-401

Ischemic Heart Disease (IHD)
Abbott Medical Devices50 enrolled10 locationsNCT07373353
Recruiting
Phase 4

LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

AnginaStable Ischemic Heart Disease
Yale University741 enrolled10 locationsNCT05786417
Recruiting
Not Applicable

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Ischemic Heart Disease
Thomas Engstrom150 enrolled1 locationNCT02445885
Recruiting
Not Applicable

Efficacy of Carbohydrate Loading in Diabetic Type 2 Patients Undergoing CABG Surgery on CPB

Heart SurgeryIschemic Heart Disease
Damascus University50 enrolled1 locationNCT06951308
Recruiting

Imaging and Physiologic Evaluation of Coronary Artery Disease

AtherosclerosisIschemic Heart Disease
Chonnam National University Hospital2,000 enrolled1 locationNCT05124249
Recruiting

Hyperpolarized MRSI in Ischemic Heart Disease: A Metabolic Investigation of the Heart Muscle

Ischemic Heart Disease
Henrik Wiggers15 enrolled1 locationNCT06054516
Recruiting

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

Coronary Artery DiseaseIschemic Heart Disease (IHD)Myocardial Viability
University of Texas Southwestern Medical Center30 enrolled1 locationNCT06047028
Recruiting

Essential Pro Study ( rEPIC04E-HK )

Coronary Artery DiseaseIschemic Heart Disease
Fundación EPIC100 enrolled1 locationNCT06631157
Recruiting
Not Applicable

Impact of Dynamic CoROnary RoADmap System for Guidance of Instantaneous Wave-Free Ratio or Fractional Flow Reserve

Ischemic Heart Disease
Yonsei University226 enrolled1 locationNCT05682118
Recruiting
Not Applicable

Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial

Coronary DiseaseCoronary Artery DiseaseIschemic Heart Disease
Fundación EPIC600 enrolled49 locationsNCT05599061
Recruiting

CMR Prognostic Markers in Ischemic Heart Disease

Myocardial Infarction (MI)Ischemic Heart Disease (IHD)
Chinese Academy of Medical Sciences, Fuwai Hospital1,000 enrolled1 locationNCT07351825
Recruiting
Not Applicable

ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO

Ischemic Heart DiseaseChronic Total Occlusion of Coronary Artery
Aarhus University Hospital Skejby1,560 enrolled27 locationsNCT03563417
Recruiting

SUPRAFLEX CRUZ PMCF Study ( rEpic05 )

Coronary Artery Disease (CAD)Ischemic Heart Disease
Fundación EPIC508 enrolled21 locationsNCT05617599